• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管造影证实的冠心病患者循环中的带负电荷低密度脂蛋白

Circulating electronegatively charged low-density lipoprotein in patients with angiographically documented coronary artery disease.

作者信息

Tomasik A, Jacheć W, Skrzep-Poloczek B, Widera-Romuk E, Wodniecki J, Wojciechowska C

机构信息

II Department of Cardiology, Silesian School of Medicine, Zabrze, Poland.

出版信息

Scand J Clin Lab Invest. 2003;63(4):259-65.

PMID:12940633
Abstract

UNLABELLED

There is growing experimental evidence to suggest the role of oxidatively modified low-density lipoprotein (LDL) in the initiation and progression of atherosclerosis. The oxidation of lipoprotein moiety causes modification of positively charged lysine residues and results in negative net charge of lipoprotein particles.

OBJECTIVE

To measure the amount of circulating electronegatively charged LDL particles (LDL-) in plasma of patients with angiographically documented coronary artery disease (CAD).

METHODS

Thirty patients were assigned to the study group (CAD+) and 10 patients to the control group (Ctrl). LDL- was quantitated in homogeneous LDL fractions obtained by ultracentrifugation, using ion exchange high performance liquid chromatography. Plasma lipids were measured using enzymatic kits.

RESULTS

The CAD+ group had significantly higher levels of LDL- in the whole LDL fraction (7.66+/-1.92 vs. 5.14+/-0.84%, p=0.0003). Moreover the CAD+ group had significantly higher levels of total cholesterol (255.4+/-35.1 vs. 210.4+/-22.4 mg/dL), LDL cholesterol (154.5+/-26.9 vs. 122.4+/-21.1 mg/dL) and significantly lower levels of high-density lipoprotein (HDL) cholesterol (40.4+/-9.4 vs. 51.0+/-11.5 mg/dL). LDL- remained significantly higher in the CAD+ group after adjustment for total cholesterol, LDL cholesterol and HDL cholesterol (6.3 vs. 5.14% at p=0.0095). There is a trend towards a positive correlation between LDL- levels and LDL cholesterol in the control group (Spearman R=0.55 at p=0.098).

CONCLUSIONS

Electronegatively charged LDL appears to be an additional hallmark of coronary artery disease, independently of established lipid risk factors. The trend towards a positive correlation between LDL cholesterol concentration and the level of LDL- in the control group may reflect the susceptibility of LDL cholesterol to autoxidation, Moreover, this may indicate other oxidative mechanisms in coronary artery disease. Nonetheless, further studies assessing the prognostic value of electronegatively charged LDLs are necessary.

摘要

未标记

越来越多的实验证据表明氧化修饰的低密度脂蛋白(LDL)在动脉粥样硬化的发生和发展中起作用。脂蛋白部分的氧化导致带正电荷的赖氨酸残基发生修饰,并使脂蛋白颗粒带负净电荷。

目的

测量经血管造影证实患有冠状动脉疾病(CAD)的患者血浆中带负电荷的LDL颗粒(LDL-)的含量。

方法

30例患者被分配到研究组(CAD+),10例患者被分配到对照组(Ctrl)。使用离子交换高效液相色谱法对通过超速离心获得的均一LDL组分中的LDL-进行定量。使用酶试剂盒测量血浆脂质。

结果

CAD+组整个LDL组分中的LDL-水平显著更高(7.66±1.92%对5.14±0.84%,p=0.0003)。此外,CAD+组的总胆固醇水平显著更高(255.4±35.1对210.4±22.4mg/dL),LDL胆固醇水平显著更高(154.5±26.9对122.4±21.1mg/dL),而高密度脂蛋白(HDL)胆固醇水平显著更低(40.4±9.4对51.0±11.5mg/dL)。在调整总胆固醇、LDL胆固醇和HDL胆固醇后,CAD+组的LDL-水平仍显著更高(6.3对5.14%,p=0.0095)。对照组中LDL-水平与LDL胆固醇之间存在正相关趋势(Spearman相关系数R=0.55,p=0.098)。

结论

带负电荷的LDL似乎是冠状动脉疾病的另一个标志,独立于已确定的脂质危险因素。对照组中LDL胆固醇浓度与LDL-水平之间的正相关趋势可能反映了LDL胆固醇对自氧化的敏感性。此外,这可能表明冠状动脉疾病中的其他氧化机制。尽管如此,有必要进一步研究评估带负电荷的LDL的预后价值。

相似文献

1
Circulating electronegatively charged low-density lipoprotein in patients with angiographically documented coronary artery disease.血管造影证实的冠心病患者循环中的带负电荷低密度脂蛋白
Scand J Clin Lab Invest. 2003;63(4):259-65.
2
Serum high-density lipoprotein-cholesterol levels modify the association between plasma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men.血清高密度脂蛋白胆固醇水平可改变男性血浆氧化型低密度脂蛋白水平与冠状动脉疾病之间的关联。
Metabolism. 2004 Apr;53(4):423-9. doi: 10.1016/j.metabol.2003.10.028.
3
A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.一项基于三级护理医院的针对已确诊冠状动脉疾病的常规风险因素(包括血脂谱)的研究。
Indian Heart J. 2003 May-Jun;55(3):234-40.
4
[Role of small dense low-density lipoprotein in coronary artery disease patients with normal plasma cholesterol levels].小而密低密度脂蛋白在血浆胆固醇水平正常的冠心病患者中的作用
J Cardiol. 2000 Dec;36(6):371-8.
5
Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS).低密度脂蛋白颗粒大小、血浆脂蛋白与冠状动脉疾病进展之间的关系:糖尿病动脉粥样硬化干预研究(DAIS)
Circulation. 2003 Apr 8;107(13):1733-7. doi: 10.1161/01.CIR.0000057982.50167.6E. Epub 2003 Mar 24.
6
Circulating non-HDL-C levels were more relevant to atherogenic lipoprotein subfractions compared with LDL-C in patients with stable coronary artery disease.在稳定型冠状动脉疾病患者中,与低密度脂蛋白胆固醇(LDL-C)相比,循环中非高密度脂蛋白胆固醇(non-HDL-C)水平与致动脉粥样硬化脂蛋白亚组分的相关性更强。
J Clin Lipidol. 2015 Nov-Dec;9(6):794-800. doi: 10.1016/j.jacl.2015.08.010. Epub 2015 Sep 3.
7
Relation of oxidized-low-density lipoprotein and high-density lipoprotein subfractions in non-treated patients with coronary artery disease.未经治疗的冠心病患者氧化型低密度脂蛋白与高密度脂蛋白亚组分的关系。
Prostaglandins Other Lipid Mediat. 2019 Oct;144:106345. doi: 10.1016/j.prostaglandins.2019.106345. Epub 2019 Jul 3.
8
Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial.在普伐他汀限制冠状动脉粥样硬化(PLAC-I)试验中脂蛋白亚类水平和低密度脂蛋白大小与冠状动脉疾病进展的关系。
Am J Cardiol. 2002 Jul 15;90(2):89-94. doi: 10.1016/s0002-9149(02)02427-x.
9
High-density lipoprotein cholesterol, C-reactive protein, and prevalence and severity of coronary artery disease in 5641 consecutive patients undergoing coronary angiography.5641例接受冠状动脉造影的连续患者的高密度脂蛋白胆固醇、C反应蛋白与冠状动脉疾病的患病率及严重程度
Eur J Clin Invest. 2008 Jun;38(6):372-80. doi: 10.1111/j.1365-2362.2008.01954.x.
10
Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in coronary artery disease.超越低密度脂蛋白胆固醇:界定低密度脂蛋白异质性在冠状动脉疾病中的作用
J Am Coll Cardiol. 2007 Oct 30;50(18):1735-41. doi: 10.1016/j.jacc.2007.07.045. Epub 2007 Oct 15.

引用本文的文献

1
Autoimmune Rheumatic Diseases: An Update on the Role of Atherogenic Electronegative LDL and Potential Therapeutic Strategies.自身免疫性风湿疾病:致动脉粥样硬化的负电性低密度脂蛋白的作用及潜在治疗策略的最新进展
J Clin Med. 2021 May 6;10(9):1992. doi: 10.3390/jcm10091992.